Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

INTRODUCTION: We previously reported that PFS may be a candidate surrogate endpoint for OS in first-line ES-SCLC using data from 3 randomized trials (Foster, Cancer 2011). In this validation study (N0424-Alliance), we assessed the patient- and trial-level surrogacy of PFS using data from 7 new first...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Thorac Oncol
Asıl Yazarlar: Foster, Nathan R., Renfro, Lindsay A., Schild, Steven E., Redman, Mary W., Wang, Xiaofei F., Dahlberg, Suzanne E., Ding, Keyue, Bradbury, Penelope A., Ramalingam, Suresh S., Gandara, David R., Shibata, Taro, Saijo, Nagahiro, Vokes, Everett E., Adjei, Alex A., Mandrekar, Sumithra J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493926/
https://ncbi.nlm.nih.gov/pubmed/26134227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000548
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller